Trial Profile
Feasibility study of S-1 and CDDP chemotherapy with short hydration for advanced Gastric Cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 06 Mar 2012 New trial record